ASCO 2021

Toripalimab Plus Gemcitabine/Cisplatin for Recurrent or Metastatic Nasopharyngeal Carcinoma

Toripalimab Immunotherapy improves treatment of recurrent or metastatic Nasopharyngeal Carcinoma

Head Neck

Radiation Therapy for Head, Neck and Oral Cavity Cancers

What to expect during radiation therapy used to treat cancer of the head, neck, or oral cavity?

Image placeholder title

Tipifarnib for HRAS-mutant Head and Neck Cancer

According to doctors at Dana Farber, Tipifarnib appears promising for treatment of certain head and neck cancers.